Last reviewed · How we verify

NCT03907839

Effects of Combined Cognitive Rehabilitation in COPD Patients

Completed NA Last updated 2 August 2019
What this trial tests

NA trial testing clinical trials in COPD in 60 participants. Completed in 15 March 2019.

Timeline
15 December 2016
Primary endpoint
15 December 2018
15 March 2019

Quick facts

Lead sponsorFaculty of Medicine, Sousse
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingdouble
Primary purposesupportive care
Enrollment60
Start date15 December 2016
Primary completion15 December 2018
Estimated completion15 March 2019

Drugs / interventions tested

Conditions studied

Sponsor

Faculty of Medicine, Sousse

Who can join

Adults 60 to 65, male only, with COPD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was to examine the effect of endurance training combined with cognitive training in patients with COPD. The intervention group underwent Cognitive Training added to Endurance Training and the control group underwent only Endurance Training.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effect of a pulmonary rehabilitation program combined with cognitive training on exercise tolerance and cognitive functions among Tunisian male patients with chronic obstructive pulmonary disease: A randomized controlled trial.
    Tabka O, Sanaa I, Mekki M, Acheche A, et al · · 2023 · cited 1× · PMID 37691169 · DOI 10.1177/14799731231201643

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

Other Faculty of Medicine, Sousse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03907839.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing